Xspray Pharma is a pharmaceutical company with several product candidates in clinical development. It uses its innovative, patented RightSize™ technology to develop improved versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.
Location: Burkina Faso, Sahel, Solna
Employees: 11-50
Founded date: 2003
Investors 1
| Date | Name | Website |
| 06.12.2021 | Flerie Inv... | flerie.com |
Mentions in press and media 2
| Date | Title | Description |
| 20.11.2020 | Xspray Pharma : publishes Interim Report Q3, January – September 2020 | ”Xspray Pharma is in an eventful phase with several crucial milestones within reach. After completing bioequivalence studies, intensive work is being done on the preparations for the Company's first ANDA application and finding the right pa... |
| 20.11.2020 | XSPRAY PHARMA AB (PUBL) Xspray Pharma : publishes Interim Report Q3, January – September 2020 | ”Xspray Pharma is in an eventful phase with several crucial milestones within reach. After completing bioequivalence studies, intensive work is being done on the preparations for the Company's first ANDA application and finding the right pa... |